| P2093 | author name string | Andersson T | |
| | Blohmé I | |
| | Idström JP | |
| P2860 | cites work | Oxidation of quinidine by human liver cytochrome P-450 | Q69598283 |
| | Cyclosporine plasma levels in renal transplant patients. Association with renal toxicity and allograft rejection | Q69882390 |
| | Ranitidine and cimetidine in renal transplantation: a clinical trial | Q70197197 |
| | Assessment of the upper gastrointestinal tract in hemodialysis patients awaiting renal transplantation | Q70261151 |
| | Reversal of histamine-mediated immunosuppression by structurally diverse histamine type II (H2) receptor antagonists | Q72592752 |
| | Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of [...] | Q28115162 |
| | Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily | Q28271091 |
| | The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction | Q34397888 |
| | Omeprazole drug interaction studies | Q36890310 |
| | Identification of an inducible form of cytochrome P-450 in human liver | Q37543129 |
| | Cyclosporine drug interactions: a review | Q39688566 |
| | Surgical prophylaxis of gastroduodenal complications associated with renal allotransplantation | Q40794598 |
| | Effects of H2-receptor antagonists on renal function in cyclosporine-treated renal transplant patients | Q41291399 |
| | The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro | Q41361363 |
| | Cyclosporine kinetics in renal transplantation | Q43679745 |
| | Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4. | Q51747037 |
| | Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4. | Q51751197 |
| | Importance of genetic factors in the regulation of diazepam metabolism: relationship to S-mephenytoin, but not debrisoquin, hydroxylation phenotype. | Q51755470 |
| | Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators. | Q54402781 |
| | Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. | Q55060683 |
| | The effects of cimetidine (Tagamet) on renal function in patients with renal failure | Q67240314 |
| | Intraindividual variability in the relative systemic availability of cyclosporin after oral dosing | Q67989789 |
| | The influence of immunosuppression on peptic ulceration following renal transplantation and the role of endoscopy | Q68090645 |
| | Oxidation of 17 alpha-ethynylestradiol by human liver cytochrome P-450 | Q68137644 |
| | Improved liquid-chromatographic determination of cyclosporine and its metabolites in blood | Q68148642 |
| | Identification of the rabbit and human cytochromes P-450IIIA as the major enzymes involved in the N-demethylation of diltiazem | Q68168999 |
| | Ranitidine, cimetidine, and the cyclosporine-treated recipient | Q68898462 |
| | A role for histamine type II (H-2) receptor binding in production of the lymphokine, soluble immune response suppressor (SIRS) | Q68999604 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cyclosporine | Q367700 |
| | omeprazole | Q422210 |
| P304 | page(s) | 156-160 | |
| P577 | publication date | 1993-02-01 | |
| P1433 | published in | British Journal of Clinical Pharmacology | Q176044 |
| P1476 | title | A study of the interaction between omeprazole and cyclosporine in renal transplant patients | |
| P478 | volume | 35 | |